Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Beijing Saite Mingqiang Pharmaceutical Technology

Request full access

AI-driven small molecule drug discovery and development

ChinaFounded 2015

About Beijing Saite Mingqiang Pharmaceutical Technology

Beijing Saite Mingqiang Pharmaceutical Technology, also known as Scitech Pharma, is a company focused on the research and development of innovative small molecule drugs. Founded in 2015 and headquartered in Beijing, the company concentrates on therapeutic areas such as oncology, autoimmune diseases, and central nervous system disorders. The legal representative for the company is Wang Kexiu.

The company's business model is centered around its proprietary AI-driven drug design and screening platform, SigmaHIT®. This technology facilitates the discovery and optimization of small molecule drug candidates, moving them from conception through preclinical studies and into clinical evaluation. Scitech Pharma has established a significant research and development infrastructure, including a 20,000-square-meter base with 11 specialized laboratories for chemistry, biology, animal studies, and more. Their drug pipeline includes several in-house projects, with some candidates advancing to Phase I and Phase II clinical trials in China. The company has secured over 100 patents, with the majority being international.

Scitech Pharma operates as a privately held, venture capital-backed entity. It has successfully completed multiple funding rounds, including a Series A round in August 2022 and a later-stage venture round in April 2024, attracting investors like Zhizhong Investment, Elikon Venture, and Hangzhou Tigermed Consulting Company.

Source: Dealroom company data

At a glance

Status
Operational
Open positions
None listed
Dealroom signal
13.7/100
Links
Website

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Apr 2024 $14M $55M Lichen Investment · Zhizhong Investment · Hangzhou Tigermed ↗
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Beijing Saite Mingqiang Pharmaceutical Technology website traffic

Latest recorded traffic for Beijing Saite Mingqiang Pharmaceutical Technology is 710 monthly website visits, up 407.1% over the last three months.

Latest monthly visits710 3-month web change+407.1%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Beijing Saite Mingqiang Pharmaceutical Technology in its local ecosystem

Live from Dealroom

The Beijing Saite Mingqiang Pharmaceutical Technology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

  • Lichen Investment
  • Zhizhong Investment
  • Hangzhou Tigermed
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Beijing Saite Mingqiang Pharmaceutical Technology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Beijing Saite Mingqiang Pharmaceutical Technology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.